Inventor · disambiguated record
Jeremy D. Pettigrew
Also filed as: PETTIGREW JEREMY · PETTIGREW JEREMY D · PETTIGREW JEREMY DAVID
18 granted patents·15 pending applications·48 citations·filing 2010–2024
91Inventor score
Files withNUVATION BIO INC13AQUINOX PHARMACEUTICALS CANADA INC8TARO PHARMACEUTICALS INC61CBIO INC3SPARCBIO LLC2
Top patents by PatentIndex Score
33 records- 0194US11834458B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2022·Granted Dec 5, 2023·2 cites·34 claims
- 0293US12006314B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2022·Granted Jun 11, 2024·2 cites·17 claims
- 0392US11584756B2Heterocyclic compounds as BET inhibitorsNUVATION BIO INC·Filed 2020·Granted Feb 21, 2023·3 cites·31 claims
- 0490US11952349B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2020·Granted Apr 9, 2024·2 cites·10 claims
- 0590US11826430B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2020·Granted Nov 28, 2023·2 cites·8 claims
- 0690US11292782B2Diarylhydantoin compounds and methods of use thereofNUVATION BIO INC·Filed 2019·Granted Apr 5, 2022·6 cites·39 claims
- 0790US11034669B2Pyrrole and pyrazole compounds and methods of use thereofNUVATION BIO INC·Filed 2019·Granted Jun 15, 2021·6 cites·16 claims
- 0888US9765085B2SHIP1 modulators and methods related theretoAQUINOX PHARMACEUTICALS (CANADA) INC·Filed 2014·Granted Sep 19, 2017·12 cites·8 claims
- 0982US9540353B2SHIP1 modulators and methods related theretoAQUINOX PHARMACEUTICALS (CANADA) INC·Filed 2014·Granted Jan 10, 2017·6 cites·19 claims
- 1080US12208141B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2023·Granted Jan 28, 2025·0 cites·19 claims
- 1179US11352367B2Indene derivatives useful in treating pain and inflammationTARO PHARMACEUTICALS INC·Filed 2019·Granted Jun 7, 2022·2 cites·38 claims
- 1278US2025276978A1Heterocyclic compounds as bet inhibitorsNUVATION BIO INC·Filed 2024·Application pending·0 cites
- 1374US2024352027A1Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2023·Application pending·0 cites
- 1473US2023339964A1Heterocyclic compounds as bet inhibitorsNUVATION BIO INC·Filed 2023·Application pending·0 cites
- 1572US2023391790A1Indene derivatives useful in treating pain and inflammationTARO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1670US10100056B2SHIP1 modulators and methods related theretoAQUINOX PHARMACEUTICALS CANADA INC·Filed 2014·Granted Oct 16, 2018·1 cites·7 claims
- 1768US11773108B2Indene derivatives useful in treating pain and inflammationTARO PHARMACEUTICALS INC·Filed 2022·Granted Oct 3, 2023·0 cites·18 claims
- 1866US8101605B2SHIP1 modulators and methods related theretoMACKENZIE LLOYD·Filed 2010·Granted Jan 24, 2012·4 cites·17 claims
- 1961US2023002366A1Indene derivatives useful in treating pain and inflammationTARO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2060US2023203089A1Hexadecahydro-1h-cyclopenta[a]phenanthrene derivatives useful in treating pain and inflammationTARO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2160US2024343710A1Heterocyclic compounds and methods of use thereof1CBIO INC·Filed 2024·Application pending·0 cites
- 2258US2024132522A1Heterocyclic compounds and methods of use thereof1CBIO INC·Filed 2023·Application pending·0 cites
- 2358US2021024571A1Hexadecahydro-1h-cyclopenta[a]phenanthrene derivatives useful in treating pain and inflammationAQUINOX PHARMACEUTICALS CANADA INC·Filed 2019·Application pending·0 cites
- 2458US2024132449A1Heterocyclic compounds and methods of use thereof1CBIO INC·Filed 2023·Application pending·0 cites
- 2556US2023174545A1Heterocyclic compounds as bet inhibitorsNUVATION BIO INC·Filed 2021·Application pending·0 cites
- 2655US2023023009A1Heterocyclic compounds and methods of use thereofSPARCBIO LLC·Filed 2021·Application pending·0 cites
- 2755US2023026856A1Heterocyclic compounds and methods of use thereofSPARCBIO LLC·Filed 2021·Application pending·0 cites
- 2853US11420962B2Indene derivatives useful in treating pain and inflammationTARO PHARMACEUTICALS INC·Filed 2019·Granted Aug 23, 2022·0 cites·58 claims
- 2953US10272081B2SHIP1 modulators and methods related theretoAQUINOX PHARMACEUTICALS CANADA INC·Filed 2018·Granted Apr 30, 2019·0 cites·2 claims
- 3051US2019023709A1Ship1 modulators and methods related theretoAQUINOX PHARMACEUTICALS CANADA INC·Filed 2018·Application pending·0 cites
- 3150US9937167B2SHIP1 modulators and methods related theretoAQUINOX PHARMACEUTICALS CANADA INC·Filed 2016·Granted Apr 10, 2018·0 cites·20 claims
- 3249US10174046B2SHIP1 modulators and methods related theretoAQUINOX PHARMACEUTICALS CANADA INC·Filed 2017·Granted Jan 8, 2019·0 cites·11 claims
- 3349US2022273659A1Heterocyclic compounds as kinase inhibitorsNUVATION BIO INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeremy D. Pettigrew files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →